Skip to main content

Volume 16 Supplement 1

Data sharing in pharma

Research

Publication of this supplement was supported by Amgen, Bayer Pharms AG and Hoffman La Roche. Articles have undergone the journal's standard peer review process for supplements. The Supplement Editor declares that they have no competing interests.

Edited by Philip Debruyne.

  1. Greater transparency and, in particular, sharing of patient-level data for further scientific research is an increasingly important topic for the pharmaceutical industry and other organisations who sponsor and...

    Authors: Katherine Tucker, Janice Branson, Maria Dilleen, Sally Hollis, Paul Loughlin, Mark J. Nixon and Zoë Williams
    Citation: BMC Medical Research Methodology 2016 16(Suppl 1):77
  2. Greater transparency, including sharing of patient-level data for further research, is an increasingly important topic for organisations who sponsor, fund and conduct clinical trials. This is a major paradigm ...

    Authors: Sally Hollis, Christine Fletcher, Frances Lynn, Hans-Joerg Urban, Janice Branson, Hans-Ulrich Burger, Catrin Tudur Smith, Matthew R. Sydes and Christoph Gerlinger
    Citation: BMC Medical Research Methodology 2016 16(Suppl 1):76
  3. Access to patient level datasets from clinical trial sponsors continues to be an important topic for the Pharmaceutical Industry as well as academic institutions and researchers. How to make access to patient ...

    Authors: Rebecca Sudlow, Janice Branson, Tim Friede, David Morgan and Caroline Whately-Smith
    Citation: BMC Medical Research Methodology 2016 16(Suppl 1):73
  4. Greater transparency and, in particular, sharing of clinical study reports and patient level data for further research is an increasingly important topic for the pharmaceutical and biotechnology industry and o...

    Authors: Nick Manamley, Steve Mallett, Matthew R. Sydes, Sally Hollis, Alison Scrimgeour, Hans Ulrich Burger and Hans-Joerg Urban
    Citation: BMC Medical Research Methodology 2016 16(Suppl 1):75

Annual Journal Metrics

  • Citation Impact
    4.622 - 2-year Impact Factor (2021)
    6.727 - 5-year Impact Factor (2021)
    2.742 - SNIP (Source Normalized Impact per Paper)
    1.933 - SJR (SCImago Journal Rank)

    Speed
    48 days to first decision for all manuscripts (Median)
    58 days to first decision for reviewed manuscripts only (Median)

    Usage 
    4,455,062 Downloads (2021)
    2,060 Altmetric mentions (2021)

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal